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Summary  
The degradation of osteoarthritic (OA) cartilage is likely related to the synthesis and the release of catabolic factors 
by chondrocytes. Nitric oxide (NO) has recently been suggested as playing a role in cartilage degradation. Since NO 
production is largely dependent on stimulation by IL-1, its effects on factors regulating the IL-1 biological activity, such 
as IL-lra, are of the utmost importance. This study examined and compared the level of NO production by normal and 
OA cartilage and chondrocytes, as well as studied the effect of IL-l-induced NO production on the synthesis and 
steady-state mRNA of interleukin-1 receptor antagonist (IL-lra). 
The NO baseline production by normal cartilage explants was undetectable but inducible by rhIL-lfl. OA cartilage 
spontaneously produced NO. About a two-fold increase in NO production was found in OA rhIL-tfl-stimulated (0.5-100 
units/ml) cartilage as compared with the similarly stimulated normal cartilage. On chondrocytes rhIL-lfl-stimulation 
(0.5-100 units/ml) produced a dose-dependent enhancement of both NO production and IL-lra synthesis. Treatment with 
200 #M Ng-monomethyl-L-arginine (L-NMA), a well known NO synthase inhibitor, induced over 70% inhibition of the 
NO production and a marked increased IL-lra synthesis (average of 84%) and expression (mRNA level). Inhibition of 
prostaglandin synthesis by indomethacin had no effect on both the NO production or the IL-lra level. 
In the present study, we demonstrated the capacity of OA cartilage to produce a larger amount of NO than the normal 
controls, both in spontaneous and IL-l-stimulated conditions. These data support the notion that, in vivo, OA 
chondrocytes are stimulated by factors, possibly IL-1, which in turn may induce the expression of NO synthase, thus 
the synthesis of NO itself. Importantly, our results showed that the elevation of NO production may be an important 
factor in the pathophysiology of OA since it can reduce IL-lra synthesis by chondrocytes. As such, an increased level 
of IL-1, associated with a decreased IL-lra level, may be responsible for the stimulation of OA chondrocytes by this 
cytokine, leading to an enhancement of cartilage matrix degradation. 
Key words: Nitric oxide, IL-lra, Cartilage, Chondrocyte, Osteoarthritis. 
Introduct ion 
THE EROSION OF osteoar thr i t i c  (OA) cart i lage is 
mediated by the re lease of catabol ic  factors  by 
chondrocytes  under  the inf luence of pro inf lamma- 
tory  cytok ines [1]. Both catabol ic  and ant ianabo l ic  
mechan isms are bel ieved to play a role in the 
deplet ion of OA cart i lage matr ix  components .  
P ro in f lammatory  cytokines,  such as IL-1 and 
TNF-~, are ins t rumenta l  in inducing both  of these 
mechan isms [1]. These cytok ines can induce the 
synthesis  of degradat ive nzymes such as metal lo-  
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proteases [2, 3] at the same t ime that  they induce 
the synthesis  of potent  enzyme act ivators  such as 
p lasminogen act ivator  and p lasmin [4, 5]. More-  
over, they may be responsib le  for reduc ing  the 
anabol ic  (repair) process by decreasing the syn- 
thesis o f  cart i lage matr ix  macromolecu les  such as 
col lagen ~ type I I  [6] and ~ aggrecan [7]. A relat ive 
deficit in one of the major  natura l  inh ib i tors  of the 
IL-1 effect, inter leukin-1 receptor  antagon is t  (IL- 
l ra),  has  been shown both  in OA and rheumato id  
ar thr i t i s  (RA) [8, 9] to be a possible cause for an  
increased level of  IL-1 act iv i ty in a r thr i t i c  
disorders. The exact  reason(s)  for the d iscoord inate  
express ion and synthes is  of IL-1 and IL - l ra  under  
these patho log ica l  condit ions remains unknown.  
However, the possible role of IL-1 in this 
phenomenon may be impor tant  as this cytok ine  
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was shown to be capable of regulating the synthesis 
of IL-lra [10]. 
Recent studies have demonstrated the presence 
o~f an increased amount of nitric oxide (NO) in OA 
and RA human synovial fluid [11]. Potential 
intra-articular sources of NO are multiple and 
include synovial fibroblasts and chondrocytes 
[12-15]. The chondrocytes possess the inducible 
form of NO synthase (iNOS) which can be 
stimulated by inflammatory cytokines uch as IL-1 
and TNF-~ [13-15]. Under IL-1 stimulation, 
chondrocytes produce NO in amounts comparable 
to the macrophages [14]. NO appears to mediate the 
IL-1 proteoglycan synthesis uppression i  articu- 
lar cartilage [16]. These observations bring forth 
the potential role of NO as a mediator of the 
pathophysiological changes taking place in 
arthritis. Moreover, the recent demonstration of
the ability of NO synthase inhibitor at reducing 
arthritic lesions in experimental models [17] 
suggests the important role that NO may play in 
arthritic diseases. 
The aims of the present study were to document 
and compare the spontaneous level of NO 
production by normal and OA cartilage, as well as 
to examine the effect of IL-lfl on the NO production 
by these tissues. Moreover, since IL-1 is a 
predominant cytokine in OA [1, 8] and that a 
relative deficit exists in OA between the synthesis 
of this cytokine and the synthesis of one of its 
major natural inhibitors, IL-lra [8, 9], we explored 
the possible implication of NO in this imbalance. 
Mater ia l s  and  Methods  
SPECIMEN SELECT ION 
Articular cartilage was obtained from the knee 
joints of patients with primary OA (68 _+ 7 years 
old, mean + S.D.) who underwent knee arthro- 
plasty, or from normal controls (56 + 12 years old) 
at post mortem within 12 h of death. The diagnosis 
of OA was based on clinical and radiological 
evaluations [18]. For normal specimens, the 
individuals had no history of joint disease, and 
each specimen was examined macroscopically to
ensure that only normal tissue was used. Immedi- 
ately after the resection of the knee, the specimens 
were kept on ice, washed with a sterile cold 
physiologic saline solution and dissected under 
aseptic conditions. 
CARTILAGE EXPLANTS 
In the first series of experiments, cartilage 
explants were obtained by dissecting full thickness 
strips of cartilage across the articular cartilage 
and processed for culture. The cartilage was cut 
into pieces (approximately 100 mg), rinsed several 
times in Dulbecco modified Eagle's medium 
(DMEM, Gibco Canadian Life Technologies, 
Burlington, Ontario, Canada), and incubated for 3 
days at 37°C in a humidified atmosphere of 5% 
CO2/95% air in DMEM containing antibiotics 
(penicillin, 100 units/ml; streptomycin, 100 #g/ml; 
Gibco) in the presence of an increasing concen- 
tration (0.5-100 units/ml) of human recombinant 
(rh) IL-lfl (Roussel Uclaf, Romainville, France). 
Each experiment was performed in duplicate. At 
the end of the incubation period, NO production 
was determined on the culture medium of each 
sample. 
In the second series of experiments, pecimens 
from OA tibial plateaus were excised from two 
areas: the fibrillated or lesioned and the non- 
fibrillated areas. The cartilage was cut into 
pieces and incubated as above in the presence or 
absence of 25 units/ml of rhIL-lfl. 
CHONDROCYTES 
Articular cartilage specimens were rinsed, 
dissected and chondrocytes released as previously 
described [19]. Briefly, sequential enzymatic diges- 
tion was performed with lmg/ml  pronase 
(Boehringer Mannheim, Indianapolis, IN, USA) for 
1 h followed by 6 h with 2 mg/ml collagenase (Type 
IA, Sigma, St-Louis, MO, USA) at 37°C in DMEM 
supplemented with 10% heat-inactivated fetal calf 
serum (FCS; Hyclone, Logan, UT, USA) and 
antibiotics, as above. Cells were seeded at high 
density (2 x 105 cells/well) in 24-well culture plates 
(#08-757-156, Corning Costar Corporation, Cam- 
bridge, MA, USA), and allowed to grow until 
confluence (about 3-4 days) in DMEM sup- 
plemented with 10% FCS and antibiotics. The 
culture medium was changed every second day and, 
24h prior to the experiment, the ceils were 
incubated in fresh serum-free medium. In order to 
ensure the chondrocyte phenotype, only high 
density primary passage cells were used. At 
confluence, the chondrocytes were incubated in the 
presence of increasing concentrations (0.5-100 
units/ml) of rhIL-lfl in the absence or presence of 
200 pM of N~-monomethyl-L-arginine-monoacetate 
(L-NMA; Calbiochem-Novabiochem Corp., San- 
Diego, CA, USA), a well known NO synthase 
inhibitor, for 3 days at 37°C in humidified 
conditions. Each experiment was performed in 
duplicate. The NO production, as well as the IL-lra 
level, were determined on the culture medium. 
Further experiments were carried out in which 
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the chondrocytes were seeded as above but in 
four-well culture plates (# 76-037-03, Flow Labora- 
tories, ICN Bioinedicals, Mississauga, Ontario, 
Canada). They were divided into the following 
groups: (1) no additive (control), (2) 25 units/ml 
rhIL-lfl, (3) 25 units/ml rhIL-lfl plus 200/~M 
L-NMA, (4) 25 units/ml rhIL-lfl, 200 ~tM L-NMA 
plus 10raM L-arginine (Sigma), (5) 25 units/ml 
rhIL-lfl plus 1.5 pg/ml indomethacin (Sigma), and 
(6) 25 units/ml rhIL-lfl plus 10 pg/ml cycloheximide 
(Sigma). The doses corresponded to the final 
concentration used for incubation. Each drug 
except indomethacin was dissolved in DMEM. 
Indomethacin was dissolved in DMEM containing 
absolute ethanol; the final concentration of 
ethanol in each well plate culture was 0.5%. For 
each experiment a control having 0.5% ethanol was 
done. Results showed no difference between the 
control with DMEM or ethanol. Media with 
additives were sterilized by pressure filtration 
(millex filters-gv 0.22#; Millipore Ltd, Missis- 
sauga, Ontario, Canada). The incubation period 
was 24 h at 37°C in humidified conditions. Each 
experiment was performed in duplicate. The NO 
production, IL-lra and prostaglandin E2 (PGE2) 
levels were determined on the culture medium, and 
the IL-lra gene expression on the chondrocytes. 
NO PRODUCTION IL- lra AND PGE2 DETERMINATIONS 
NO production was determined by the measure- 
ment of the nitrite release using the Griess 
reaction [20]. Measurement of IL-lra was accom- 
plished using a specific ELISA from Research and 
Diagnostics Systems (Minneapolis, MN, USA)i the 
sensitivity was 6.5 pg/ml. PGE2 was measured using 
the Amersham scintillation proximity assay (SPA; 
Amersham Corp., Oakville, Ontario, Canada) 
system using 1125II-PGE2, according to the manufac- 
turer's protocol. The sensitivity of the assay was 
8-10pg/ml. Assays under each condition were 
performed in triplicate, following the manufac- 
turer's instructions. 
IL- lra mRNA EXPRESSION:  NORTHERN BLOTTING 
Total RNA was isolated as previously de- 
scribed [21]. Briefly, chondrocytes were lysed in a 
preheated buffer (60°C) containing 20 mM sodium 
acetate, pH 5, 0.5% sodium dodecyl sulfate (SDS) 
and 1 mM EDTA. The lysate was then extracted 
twice with preheated phenol (60°C) in 20mM 
sodium acetate, pH 5. The aqueous phase was 
precipitated overnight with three volumes of 
absolute thanol at -20°C. After being centrifuged 
(20min, 13,000g, 4°C), the RNA pellet was 
solubilized in sterile water a~d the RNA quanti- 
tated spectrophotometrically. 
Five micrograms of the total RNA were resolved 
on 1.2% agarose-formaldehyde gel. Twenty-eight S 
and 18 S ribosomal RNA bands were visualized 
using ethidium bromide staining. Following trans- 
fer to a nylon membrane (Hybond N, Amersham 
Corp.) in 10 mM sodium acetate buffer, pH 7.8 
containing 20 mM Tris and 0.5 mM EDTA, overnight 
at 4°C, the RNA was cross-linked to the membrane 
by exposure to u.v. light. 
Human IL-lra probes were constructed by 
cloning the reverse transcriptase polymerase chain 
reaction (RT-PCR) amplified fragments from syn- 
ovial fibroblasts into the EcoRV site of pBluescript 
SK + vector. The RT-PCR was performed according 
to the instructions from Perkin-Elmer Cetus 
(Norwalk, CT, USA) and carried out with GENE 
ATAQ controller (Pharmacia LKB, Mississauga, 
Ontario, Canada) as previously described [21]. The 
primer sequences for the sense was 5'-CTCTGGGA- 
GAAAATCCAGCAAG-3' and 5'-CTTCGTCAG- 
GCATATTGGTGAG-3' for the antisense 
corresponding to positions 149-174bp and 540- 
561 bp respectively, of the published sequence [22]. 
The size of the amplified fragment was 413 bp. The 
identity of the fragment was verified by treating the 
PCR product with Kpn I. By analyzing the 
resultant fragments by agarose gel electrophoresis, 
we obtained the expected (according to the 
published sequence, 22) bands at 143 and270 bp. 
Prehybridization was performed for 18 h at 68°C 
in a 5 × SSC buffer (20×: 200 mM sodium citrate, 3 M 
NaC1, pH 7) containing 50% formamide, 7% SDS, 
0.1% N-lauroyl-sarcosine, 2% blocking reagent 
(purified casein fraction in 100 mM maleic acid and 
150 mM NaC1, pH 7.5), 10 #g/ml polyadenylic acid 
and 50pg/ml denatured salmon tested DNA. 
Hybridization was carried out in the same buffer 
containing 50 ng/ml antisense RNA IL-lra labeled 
with digoxigenin-ll uridyl triphosphate (DIG-11- 
UTP) (Boehringer Mannheim, Laval, Quebec, 
Canada) for 18 h at 68°C. Stringent serial post-hy- 
bridization washes were carried out with a final 
one in a 0.1×SSC buffer, followed by a brief 
washing in a maleate buffer (100 m~ maleic acid, 
150 mM NaC1, pH 7.5) containing 0.3% Tween-20 
(Sigma). The detection was done with Lumigen 
PPD [4-methoxy-4-(3-phosphatephenyl) spiro-(1,2- 
dioxetane-3,2'-adamantane) disodium salt] as sub- 
strate for alkaline phosphatase conjugated to 
anti-DIG antibody Fab-fragments, as described in 
the Boehringer Mannheim user's guide 
(Boehringer Mannheim GM 6H, Germany, 1993). 
The membranes were then subjected to auto- 
radiography using Kodak XAR5 films (Eastman 




1.4  - -  
1.2-  
1.0-  
0 .8-  
0 ,6-  
0 .4-  




1 2 5 10 25 5O 
¢~:!,F'¢" 
100 0.5 1 2 
rhIL-lfl (units/ml) 
Osteoarthritic 
///;" ~ x .c  .,? , :  
5 10 
x~;? ) ; ;S4  
!t ~:?";;; ~'f4:~//. 
25 50 100 
Fro. 1. Human normal (N= 3) and OA (N= 3) knee cartilage xplants were cultured in medium for 3 days in the presence 
of an increasing amount of rhIL-lfl (0.5-100 units/ml). The level of NO production was measured via the amount of 
nitrite release in the medium, following the Greiss reaction. Values are expressed per mg tissue wet weight, and data 
represented as the mean + S.E.M. 
Kodak LTD, Rochester, NY, USA) at room 
temperature. Autoradiography was subjected to 
laser scanning densi tometry (GS-300 Hoefer Scien- 
tific Instruments,  San Francisco, CA, USA) for 
mRNA measurement,  and the results calculated as 
the relative expression ormal ized to 28 S RNA. 
Resu l ts  
Under unst imulated condit ions, NO was pro- 
duced only in trace amounts  in  normal  cart i lage 
explants. Upon rhIL-lf l  st imulation, the NO 
product ion slowly increased, start ing at a concen- 
t rat ion of 1 unit/ml and in a dose-dependent 
manner  (Fig. 1). In contrast,  OA cart i lage explants 
spontaneous ly  produced NO at a level 
(0 .27_ 0.02 nmole/mg tissue wet weight of nitr ite 
release) similar to the one found in normal  controls 
upon st imulat ion with 10 units/ml of rhIL-lfl. As 
for normal  cartilage, rhIL-lf l  induced a dose-depen- 
dent elevation of NO production. Upon maximal 
st imulat ion (IL-1/?~ 50 units/ml) OA carti lage 
produced about twice as much NO as normal  
explants (Fig. 1). Under  these experimental  
condit ions L-NMA, at a concentrat ion of 200 ttM, 
induced over 80% inhibit ion of the NO product ion 
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FIG. 2. Human articular cartilage chondrocytes (N= 2) in primary monolayer were cultured for 3 days in the presence 
of inceasing concentrations of rhIL-lfl (0.5-100 units/m]) and in the absence or presence of L-NMA (200 #M). Levels 
of (a) NO production and (b) IL-lra were measured in the culture medium. Values are expressed per 2 x 105 cells, and 
data represented as the mean. 
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(data not illustrated). Knowing that in OA 
cartilage, the chondrocytes from different location 
sites may behave differently, OA tibial plateaus 
were dissected according to the fibrillated or 
lesional area and non-fibrillated area. The carti- 
lage NO baseline production from the fibrillated 
area (0.14+0.01nmole/mg tissue wet weight) 
tended to be slightly higher than the one from the 
non-fibrillated sites (0.09 _+ 0.03nmole/mg tissue 
wet weight). However, upon rhIl-lfl stimulation, (25 
units/ml) a similar level of nitrite was found for 
both cartilage sites (fibrillated, 0.54 ___ 0.22; non- 
fibrillated, 0.49 +_ 0.14 nmole/mg tissue wet weight). 
Preliminary experiments assessing various time 
periods (0-7 days) as well as L-NMA concentrations 
(0-1000#M) revealed that NO production from 
IL-lfl-stimulated chondrocytes increased slowly, 
reaching a plateau at 3 days of incubation which 
remained stable until at least the seventh day. 
L-NMA induced a rapid NO production decline in 
which 25#M showed a 60% inhibition and 
proceeded slowly with a 90% inhibition at 200 FtM 
and 98% at 1000#M. Therefore, all subsequent 
experiments were performed with a 3-day incu- 
bation period (unless otherwise stated), and using, 
when appropriate, 200 #M L-NMA. 
The production of NO by human chondrocytes 
under stimulation with IL-lfl also demonstrated a 
dose-response curve which reached a plateau at 
around 25 units/ml [Fig. 2(A)]. The addition of 
200 #M of L-NMA induced a 93% to 70% decrease 
in NO production from 0.5-100 units/ml of 
IL-lfl-stimulated cells, respectively. Interleukin-lfl 
also induced an increased synthesis of IL-lra 
[Fig. 2(B)]. However, when the production of NO 
was blocked by L-NMA (200 pM), an enhancement 
of the IL-lra synthesis was found over the IL-1 
control value [Fig. 2(B)]; an  average increase of 
84% (starting at 5 units/ml IL-!fl) in the IL-lra level 
was found in the presence of L-NMA, which 
appeared to correspond to the decrease in the 
production of NO [Fig. 2(A)]. 
Furthermore, additional experiments were car- 
ried out for which the effect of L-NMA, L-arginine, 
indomethacin and cycloheximide were evaluated 
for their effect on NO production, PGE2 and IL-lra 
synthesis [Fig. 3(A)] as well as on IL-lra gene 
expression [Fig. 3(B)]. Results showed that L- 
arginine partially reversed the effect of L-NMA for 
both NO production and IL-lra. Indomethacin 
inhibited over 75% of the PGE2 synthesis (data not 
illustrated) but had no effect on the IL-1 -induced 
nitrite level nor on the IL-lra synthesis [Fig. 3(A)]. 
Cycloheximide, on the other hand, suppressed NO 
production by 60% and IL-lra synthesis by 94%. As 
illustrated in Fig. 3(B)] rhIL-lfl produced a 
significant enhancement of the steady state level of 
IL-lra mRNA, which was further enhanced when 
NO production was blocked by L-NMA. As for the 
protein, the effect of L-NMA on the IL-lra gene 
expression was also reversed by the addition of 
L-arginine. Interestingly, cycloheximide exhibited 
a 67% inhibition of the IL-lfl-induced level of 
IL-lra mRNA. 
Discuss ion  
In the present study, we demonstrated that OA 
cartilage has the capacity to spontaneously 
produce NO, and in a larger amount han in normal 
cartilage especially when stimulated with IL-lfl. 
These data, support the notion, that in vivo, OA 
chondrocytes are stimulated by factors which may, 
in turn, induce the expression of NO synthase, thus 
the synthesis of NO. The factors which may 
stimulate the NO production by the chondrocytes 
include several proinflammatory c tokines uch as 
IL-1, TNF-~ and LIF (13, 14, 23, 24). At this time, it 
is tempting to speculate whether IL-1 is the likely 
candidate involved in this process, as this cytokine 
is the most abundant and predominant in OA 
tissues [1]. The in situ presence, in OA cartilage 
[25, 26] of IL-1 may in fact explain why, when the 
OA explants were stimulated by IL-1, that very 
little increase of NO production was observed at 
concentration of IL-lfl less than 5 units/ml. 
Moreover, OA chondrocytes appeared to be hyper- 
responsive to IL-1 stimulation as twice as much 
nitrite was found when OA cells were compared to 
normal. A similar phenomenon has previously 
been reported by our group with respect to 
metalloprotease synthesis [19] and seems related to 
an increased level of IL-1 receptor in OA 
chondrocytes [19]. 
Interestingly, the production of NO appeared to 
be uniform throughout the OA cartilage and only 
a slight increase was found in fibrillated cartilage. 
This observation may reflect the fact that the 
stimuli responsible for the increased production of 
NO, an upregulation of the inducible NO synthase 
(iNO~), is a factor which can diffuse within the 
articular cartilage. In addition, this could also 
result from a diffusion of an inflammatory cytokine 
such as IL-1 from the synovium. The fact that 
chondrocytes from both OA cartilage sites were 
equally responsive to the IL-1 treatment is strongly 
indicative that thecel ls from either area conserved 
equal capacity to express the iNOS gene. The 
increased level of NO detected in the synovial fluid 
of OA and RA patients [27] predominately 
originates from an increased level of NO pro- 
duction by the cartilage chondrocytes as human 
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